Cancer researcher named first STAT Biomedical Innovation Award winner
Dr. Charles Sawyers played a major role in the development of the blockbuster drugs Gleevec for leukemia and Xtandi for prostate cancer.
Thrilled to be recognized by
- Thank you for a great day on
campus w talented reporters who bring much needed attention to the biomedical community
Dr. Charles Sawyer, who helped develop the blockbuster cancer drugs Gleevec and Xtandi, has been named the first STAT Biomedical Innovation Award winner. #STATSummit
The inaugural winner of the
Biomedical Innovation Award is Charles Sawyers, whose work has made a difference in countless lives. #STATSummit
Longtime cancer researcher, innovator focused on drug resistance,
Dream Team co-leader
named first STAT Biomedical Innovation Award winner
Here are some highlights from this week's #STATsummit: Machine learning experts:
Cancer researcher named first STAT Biomedical Innovation Award winner #STATsummit
Congratulations: Longtime cancer researcher Charles Sawyers named first STAT Biomedical Innovation Award winner
Anas Younes, M.D.
Longtime cancer researcher Charles Sawyers named first STAT Biomedical Innovation Award winner